Evidence
J Clin Invest. 2024 Mar 1;134(5):e175036. doi: 10.1172/JCI175036.
ABSTRACT
Fragile X syndrome (FXS), the most common inherited cause of intellectual disability and the single-gene cause of autism, is caused by decreased expression of the fragile X messenger ribonucleoprotein protein (FMRP), a ribosomal-associated RNA-binding protein involved in translational repression. Extensive preclinical work in several FXS animal models supported the therapeutic potential of decreasing metabotropic glutamate receptor (mGluR) signaling to correct translation of proteins related to synaptic plasticity; however, multiple clinical trials failed to show conclusive evidence of efficacy. In this issue of the JCI, Berry-Kravis and colleagues conducted the FXLEARN clinical trial to address experimental design concerns from previous trials. Unfortunately, despite treatment of young children with combined pharmacological and learning interventions for a prolonged period, no efficacy of blocking mGluR activity was observed. Future systematic evaluation of potential therapeutic approaches should evaluate consistency between human and animal pathophysiological mechanisms, utilize innovative clinical trial design from FXLEARN, and incorporate translatable biomarkers.
PMID:38426491 | DOI:10.1172/JCI175036
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Challenges in developing therapies in fragile X syndrome: how the FXLEARN trial can guide research
🌐 90 Days
VR Related Evidence Matrix
- mGluR7 allosteric modulator AMN082 corrects protein synthesis and pathological phenotypes in FXS
- Characterization of ribosome stalling and no-go mRNA decay stimulated by the Fragile X protein, FMRP
- Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients
- Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence
- Bisphenol F affects neurodevelopmental gene expression, mushroom body development and behavior in Drosophila melanogaster
- A holistic approach to fragile X syndrome integrated guidance for person-centred care
- Topography and ensemble activity in auditory cortex of a mouse model of Fragile-X-Syndrome
- Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: obligatory role of hippocampal GPR55 receptors
- ADNP dysregulates methylation and mitochondrial gene expression in the cerebellum of a Helsmoortel-Van der Aa syndrome autopsy case
- SynGAP regulates synaptic plasticity and cognition independently of its catalytic activity
- Serotonin Signaling through Lipid Membranes
- Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndrome
- SHP2 regulates GluA2 tyrosine phosphorylation required for AMPA receptor endocytosis and mGluR-LTD
- Molecular profiling of the hippocampus of children with autism spectrum disorder
- Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research
- Selective vulnerability of the ventral hippocampus-prelimbic cortex axis parvalbumin interneuron network underlies learning deficits of fragile X mice
- Ligand-gated ion channels as potential biomarkers for ADT-mediated cognitive decline in prostate cancer patients
- Ribosomal quality control factors inhibit repeat-associated non-AUG translation from GC-rich repeats
- Meeting report of the fifth annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease Research
- Altered lipid homeostasis is associated with cerebellar neurodegeneration in SNX14 deficiency
- Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
- Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron
- Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome
- The CHD family chromatin remodeling enzyme, Kismet, promotes both clathrin-mediated and activity-dependent bulk endocytosis
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease
- Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Single-sequence protein structure prediction by integrating protein language models
- Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5R59X knock-in mice
- Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson's disease
- GABAergic/glycinergic and glutamatergic neurons mediate distinct neurodevelopmental phenotypes of STXBP1 encephalopathy
- Analyzing the Quality of Life in Individuals with Fragile X Syndrome in Relation to Sleep and Mental Health
- Insights into amyloid precursor protein target through PPI network analysis
- Voltage tunes mGlu5 receptor function, impacting synaptic transmission
- Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia
- The autism susceptibility kinase, TAOK2, phosphorylates eEF2 and modulates translation
- Loss-of-function of activity-dependent neuroprotective protein (ADNP) by a splice-acceptor site mutation causes Helsmoortel-Van der Aa syndrome
- Quantitative assessment of preanalytic variables on clinical evaluation of PI3/AKT/mTOR signaling activity in diffuse glioma
- Disentangling tau: One protein, many therapeutic approaches
- TREX tetramer disruption alters RNA processing necessary for corticogenesis in THOC6 Intellectual Disability Syndrome
- Protein Research Seminar
- Tmod2 is a regulator of cocaine responses through control of striatal and cortical excitability, and drug-induced plasticity
- NUS1 Variants Cause Lennox-Gastaut Syndrome Related to Unfolded Protein Reaction Activation
- The novel peptide LCGM-10 attenuates metabotropic glutamate receptor 5 activity and demonstrates behavioral effects in animal models
- Interferon-a receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy
- Lymphoblast transcriptome analysis in 22q11.2 deletion syndrome individuals with schizophrenia-spectrum disorder
- Orexins and primary headaches: an overview of the neurobiology and clinical impact
- IL-8+ neutrophils drive inexorable inflammation in severe alcohol-associated hepatitis
- Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a Drosophila knock-in tauopathy model
- Tiam1 regulates proliferation, invasion, and differentiation in neuroblastoma through the Tiam1/Rac1 signaling pathway
- Edaravone dexborneol attenuates cognitive impairment in a rat model of vascular dementia by inhibiting hippocampal oxidative stress and inflammatory responses and modulating the NMDA receptor signaling pathway
- The central renin-angiotensin system: A genetic pathway, functional decoding, and selective target engagement characterization in humans
- DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD
- Refining the 9q34.3 microduplication syndrome reveals mild neurodevelopmental features associated with a distinct global DNA methylation profile
- Undiagnosed rare disease clinic identifies a novel UBE3A variant in two sisters with Angelman syndrome: The end of a diagnostic odyssey
- Potential role of the lncRNA "HOTAIR"/miRNA "206"/BDNF network in the alteration in expression of synaptic plasticity gene arc and BDNF level in sera of patients with heroin use disorder through the PI3K/AKT/mTOR pathway compared to the controls
- Angiostrongylus cantonensis induces energy imbalance and dyskinesia in mice by reducing the expression of melanin-concentrating hormone
- Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment
- Sleep need driven oscillation of glutamatergic synaptic phenotype
- Sleep need driven oscillation of glutamatergic synaptic phenotype
- Adaptation of Magnified Analysis of the Proteome for Excitatory Synaptic Proteins in Varied Samples and Evaluation of Cell Type-Specific Distributions
- The Phenotypic Spectrum of Desanto-Shinawi Syndrome: A Comparative Report of the First Reported Case in Turkey
- Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes
Evidence Blueprint
Challenges in developing therapies in fragile X syndrome: how the FXLEARN trial can guide research
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Challenges in developing therapies in fragile X syndrome: how the FXLEARN trial can guide research
🌐 365 Days
VR Related Evidence Matrix
- The potential role of ribonucleic acid methylation in the pathological mechanisms of fragile X syndrome
- On-Tissue Spatial Proteomics Integrating MALDI-MS Imaging with Shotgun Proteomics Reveals Soy Consumption-Induced Protein Changes in a Fragile X Syndrome Mouse Model
- mGluR7 allosteric modulator AMN082 corrects protein synthesis and pathological phenotypes in FXS
- CNS-dominant human FMRP isoform rescues seizures, fear, and sleep abnormalities in Fmr1-KO mice
- Neurodevelopment and early pharmacological interventions in Fragile X Syndrome
- Effects of AFQ056 on language learning in fragile X syndrome
- Characterization of ribosome stalling and no-go mRNA decay stimulated by the Fragile X protein, FMRP
- Phenotypic variability to medication management: an update on fragile X syndrome
- Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients
- Dysregulated COMT Expression in Fragile X Syndrome
- Peripheral Fragile X messenger ribonucleoprotein is required for the timely closure of a critical period for neuronal susceptibility in the ventral cochlear nucleus
- Investigating cell-specific effects of FMRP deficiency on spiny projection neurons in a mouse model of Fragile X syndrome
- Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence
- Bisphenol F affects neurodevelopmental gene expression, mushroom body development and behavior in Drosophila melanogaster
- Fragile X Syndrome and Fetal Alcohol Syndrome: Occurrence of Dual Diagnosis in a Set of Triplets
- Novel Presynaptic Assay System Revealed That Metformin Ameliorates Exaggerated Synaptic Release and Munc18-1 Accumulation in Presynapses of Neurons from Fragile X Mouse Model
- Cerebellar contribution to autism-relevant behaviors in fragile X syndrome models
- Rescue of sharp wave-ripples and prevention of network hyperexcitability in the ventral but not the dorsal hippocampus of a rat model of fragile X syndrome
- Progranulin is an FMRP target that influences macroorchidism but not behaviour in a mouse model of Fragile X Syndrome
- Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons
- A novel combination treatment for fragile X syndrome predicted using computational methods
- Excitatory neuron-specific suppression of the integrated stress response contributes to autism-related phenotypes in fragile X syndrome
- Fragile X Syndrome in children
- A holistic approach to fragile X syndrome integrated guidance for person-centred care
- Similar Gap-Overlap Profiles in Children with Fragile X Syndrome and IQ-Matched Autism
- Topography and ensemble activity in auditory cortex of a mouse model of Fragile-X-Syndrome
- The atypical 'hippocampal' glutamate receptor coupled to phospholipase D that controls stretch-sensitivity in primary mechanosensory nerve endings is homomeric purely metabotropic GluK2
- Enrichment of the local synaptic translatome for genetic risk associated with schizophrenia and autism spectrum disorder
- Increased body weight in mice with fragile X messenger ribonucleoprotein 1 (Fmr1) gene mutation is associated with hypothalamic dysfunction
- Hippocampal Upregulation of Complement Component C3 in Response to Lipopolysaccharide Stimuli in a Model of Fragile-X Syndrome
- Neural correlates of face processing among preschoolers with fragile X syndrome, autism spectrum disorder, autism siblings, and typical development
- FMRP expression in primary breast tumor cells correlates with recurrence and specific site of metastasis
- Developmental Impairments of Synaptic Refinement in the Thalamus of a Mouse Model of Fragile X Syndrome
- Language Skills Influence Transition Planning in Adolescents With Fragile X Syndrome
- Differential Effects of a Behavioral Treatment Probe on Social Gaze Behavior in Fragile X Syndrome and Non-Syndromic Autism Spectrum Disorder
- Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need
- Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: obligatory role of hippocampal GPR55 receptors
- Bridging the translational gap: what can synaptopathies tell us about autism?
- Increased degradation of FMRP contributes to neuronal hyperexcitability in tuberous sclerosis complex
- ADNP dysregulates methylation and mitochondrial gene expression in the cerebellum of a Helsmoortel-Van der Aa syndrome autopsy case
- Prolonged and specific spatial training during adolescence reverses adult hippocampal network impairments in a mouse model of fragile X syndrome
- SynGAP regulates synaptic plasticity and cognition independently of its catalytic activity
- Unravelling the link between neurodevelopmental disorders and short tandem CGG-repeat expansions
- Abnormal Brain Oscillations in Developmental Disorders: Application of Resting State EEG and MEG in Autism Spectrum Disorder and Fragile X Syndrome
- New cases of recently described Thauvin-Robinet-Faivre syndrome with a novel homozygous FIBP gene variant
- Hypnotic treatment reverses NREM sleep disruption and EEG desynchronization in a mouse model of Fragile X syndrome to rescue memory consolidation deficits
- Serotonin Signaling through Lipid Membranes
- Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
- Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndrome
- Glial dysregulation in the human brain in fragile X-associated tremor/ataxia syndrome
- Autism- and epilepsy-associated EEF1A2 mutations lead to translational dysfunction and altered actin bundling
- SHP2 regulates GluA2 tyrosine phosphorylation required for AMPA receptor endocytosis and mGluR-LTD
- Molecular profiling of the hippocampus of children with autism spectrum disorder
- Systemic pharmacological suppression of neural activity reverses learning impairment in a mouse model of Fragile X syndrome
- Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders
- Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research
- Selective vulnerability of the ventral hippocampus-prelimbic cortex axis parvalbumin interneuron network underlies learning deficits of fragile X mice
- Cyfip2 controls the acoustic startle threshold through FMRP, actin polymerization, and GABA B receptor function
- Behavioural and physiological indicators of anxiety reflect shared and distinct profiles across individuals with neurogenetic syndromes
- Improvement of sensory deficits in fragile X mice by increasing cortical interneuron activity after the critical period
- Ligand-gated ion channels as potential biomarkers for ADT-mediated cognitive decline in prostate cancer patients
- Developmental delays in cortical auditory temporal processing in a mouse model of Fragile X syndrome
- Novel MeCP2 Gene Therapy is Effective in a Multicenter Study using Two Mouse Models of Rett Syndrome and is Safe in Non-human Primates
- Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome